Drug Shortage Report for TAMIFLU

Last updated on 2020-04-21 History
Report ID 105912
Drug Identification Number 02381842
Brand name TAMIFLU
Common or Proper name Oseltamivir Phosphate
Company Name HOFFMANN-LA ROCHE LIMITED
Market Status MARKETED
Active Ingredient(s) OSELTAMIVIR
Strength(s) 6MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size 100 mL glass bottles with a bottle adapter and 1 oral dispenser
ATC code J05AH
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-03-01
Actual start date 2020-03-10
Estimated end date 2020-03-31
Actual end date 2020-04-20
Shortage status Resolved
Updated date 2020-04-21
Company comments Roche will manage the supply of current inventory until the end of February. We anticipate availability of new stock by the end of March.
Health Canada comments
Tier 3 Status No
Contact Address 7070 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 5M8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-04-21 English Compare
v8 2020-04-20 French Compare
v7 2020-04-20 English Compare
v6 2020-03-11 English Compare
v5 2020-03-10 French Compare
v4 2020-03-10 English Compare
v3 2020-03-02 English Compare
v2 2020-02-13 French Compare
v1 2020-02-13 English Compare

Showing 1 to 9 of 9